Ectopic expression of interleukin-1 receptor type II enhances cell migration through activation of the pre-interleukin 1alpha pathway.

Expression of interleukin-1 receptor type II (IL1R2), a decoy receptor for pro-inflammatory interleukin 1 (IL-1), is enhanced by chronic exposure of the human uroepithelial cell line HUC-1 to arsenite. To explore the function of IL1R2, we ectopically expressed IL1R2 in HUC-1 cells. IL1R2 overexpression results in changes in cell morphology, actin rearrangement, and promoted cell migration. Ectopic expression of IL1R2 specifically blocked exogenous IL-1beta signaling but increased expression of the precursor form of IL-1alpha (pIL-1alpha) and its downstream targets, including interleukin 6 (IL-6), interleukin 8 (IL-8), and type I collagen alpha1 (COL1A1). However, depleting gene expression using small RNA interference specific to either pIL-1alpha or COL1A1, but not IL-6 or IL-8, significantly attenuated the migration of IL1R2-overexpressing cells. Furthermore, IL1R2 overexpression was associated with enhanced expression of Smad-interacting protein 1 (SIP-1) and reduced expression of E-cadherin. Because SIP-1 is a repressor of COL1A1-induced E-cadherin expression, the present results suggest that IL1R2 overexpression is likely through activation of the pIL-1alpha pathway to enhance cell migration.

[1]  D. Roeder,et al.  Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. , 1990, Science.

[2]  J. Maier,et al.  Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells , 1994, Molecular and cellular biology.

[3]  T. Maciag,et al.  Intracellular Precursor Interleukin (IL)-1α, but Not Mature IL-1α, Is Able to Regulate Human Endothelial Cell Migration in Vitro * , 1997, The Journal of Biological Chemistry.

[4]  C. D’Souza-Schorey.  Disassembling adherens junctions: breaking up is hard to do. , 2005, Trends in cell biology.

[5]  C. Reznikoff,et al.  Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. , 1987, Cancer research.

[6]  K. Huebner,et al.  A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. , 1991, The EMBO journal.

[7]  M. Gayle,et al.  Interleukin 1 signaling occurs exclusively via the type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[9]  G. Adler,et al.  Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. , 2001, Cancer research.

[10]  N. Kamatani,et al.  Intracellular IL-1α-binding proteins contribute to biological functions of endogenous IL-1α in systemic sclerosis fibroblasts , 2006, Proceedings of the National Academy of Sciences.

[11]  A. H. Drummond,et al.  Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor* , 1997, The Journal of Biological Chemistry.

[12]  M. Gadina,et al.  IL-33: A Sheep in Wolf’s Clothing? , 2007, Science's STKE.

[13]  T. Gress,et al.  Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer , 2007, Oncogene.

[14]  G. Adler,et al.  Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. , 2006, Cancer research.

[15]  R. Locksley,et al.  The N-terminal propiece of interleukin 1α is a transforming nuclear oncoprotein , 1997 .

[16]  Te-Chang Lee,et al.  Distinct Gene Expression Profiles in Immortalized Human Urothelial Cells Exposed to Inorganic Arsenite and Its Methylated Trivalent Metabolites , 2005, Environmental health perspectives.

[17]  S. Brown,et al.  Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. , 1993, The Journal of biological chemistry.

[18]  Te-Chang Lee,et al.  Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  T. Simmet,et al.  Intracellular Interleukin-1α Functionally Interacts with Histone Acetyltransferase Complexes* , 2004, Journal of Biological Chemistry.

[20]  A. Mantovani,et al.  The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. , 1994, Immunology today.

[21]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[22]  V. Murthy,et al.  Endogenous interleukin-1 alpha promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells. , 2007, American journal of physiology. Heart and circulatory physiology.

[23]  Y. Iwakura,et al.  IL-1 is required for tumor invasiveness and angiogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Labow,et al.  Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.

[25]  S. Dower,et al.  Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis. , 1995, Journal of immunology.

[26]  T. Lee,et al.  Sodium arsenite disturbs mitosis and induces chromosome loss in human fibroblasts. , 1997, Cancer research.

[27]  M. Muda,et al.  Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. , 1995, The American journal of pathology.

[28]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[29]  T. Kupper,et al.  Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[31]  A. Mantovani,et al.  Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function , 1996, The Journal of experimental medicine.

[32]  H. Sheng,et al.  Prostaglandin E2 Induces the Expression of IL-1α in Colon Cancer Cells1 , 2007, The Journal of Immunology.

[33]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[34]  D. Boraschi,et al.  The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. , 1998, Journal of immunology.

[35]  C. Dinarello,et al.  The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M Locati,et al.  Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.

[37]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[38]  H. Carlsen,et al.  Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. , 2005, Arthritis and rheumatism.

[39]  C. Dinarello.  The many worlds of reducing interleukin-1. , 2005, Arthritis and rheumatism.

[40]  T. Wright,et al.  A nuclear target for interleukin-1α: Interaction with the growth suppressor necdin modulates proliferation and collagen expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.